EDX Medical develops rapid pneumonia test for hospital patients
August 11, 2025
EDX claims the test, which is intended for use in the ICU, provides results for guiding treatment decisions within 60 seconds.
EDX claims the test, which is intended for use in the ICU, provides results for guiding treatment decisions within 60 seconds.
The introduction of the test is underpinned by data from the blinded, prospective EXPAND study, which began in 2023.
Uppsala University Hospital-led investigators report that gene-edited donor islet cells survived 12 weeks inside a man with long-standing type 1 diabetes without any immunosuppressive medication.
Researchers from Helmholtz Munich, the Technical University of Munich (TUM), and the Medical University of Vienna have developed an advanced imaging technique called “O2E” that allows clinics to detect cancerous lesions in the esophagus with unprecedented precision.
Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease, is an incurable neurological disorder affecting motor neurons—nerve cells in the brain and spinal cord that control voluntary muscle movement and breathing.
BMI OrganBank is developing novel medical devices with potential to significantly reduce the waitlist for lifesaving organ transplants, beginning with kidneys
In a small new study, a handheld saliva-sampling device successfully detected breast cancer 100% of the time, researchers said.
Using a custom-built tool to analyze the electrical activity from neurons, researchers at Brown University have identified a brain-based biomarker that could be used to predict whether mild cognitive impairment will develop into Alzheimer’s disease.
New research has uncovered a novel mechanism that may help explain why some people with cancer respond remarkably well to immunotherapy while others don’t.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a “two-in-one” molecule that can simultaneously turn off two notoriously difficult-to-target cancer-related genes, KRAS and MYC, as well as directly deliver drugs to tumors that express these genes. This advance holds special promise for treating cancers that have been historically challenging to treat.